It occurs in atrial, ventricular, and conduction system cells. In ventricular myocardium, it is more potent in the epicardium than the endocardium; this transmural Ito1 gradient underlies the J wave ECG finding.[3]
Role in disease
Reduction in Ito1 density is associated with prolonged action potentials and is a common finding in cardiac disease.[4]
Ito1 density is significantly lower in the cells of a failing heart in comparison to the cells of a healthy heart.[5]
Ito activation is inhibited by thyrotropin (TSH).[7] This mechanisms may be one of the reasons for the observation that both bradycardia and atrial fibrillation are common in hypothyroidism.[8][9][10]
An increase in the Ito1 density caused by a mutation in Kv4.3 can be a cause of Brugada Syndrome.[11]
^Greger R, Windhorst U (1996). Comprehensive Human Physiology: From Cellular Mechanisms to Integration. Berlin, Heidelberg: Springer. p. 1828. ISBN978-3-642-60946-6.
^ abcAsirvatham SJ, ed. (2014). Mayo Clinic Electrophysiology Manual. Oxford: Mayo Clinic Scientific Press/Oxford University Press. p. 174. ISBN978-0-19-933041-6.
^Oudit GY, Kassiri Z, Sah R, Ramirez RJ, Zobel C, Backx PH (May 2001). "The molecular physiology of the cardiac transient outward potassium current (I(to)) in normal and diseased myocardium". Journal of Molecular and Cellular Cardiology. 33 (5): 851–872. doi:10.1006/jmcc.2001.1376. PMID11343410. S2CID829154.
^Brandt MC, Priebe L, Böhle T, Südkamp M, Beuckelmann DJ (October 2000). "The ultrarapid and the transient outward K(+) current in human atrial fibrillation. Their possible role in postoperative atrial fibrillation". Journal of Molecular and Cellular Cardiology. 32 (10): 1885–1896. doi:10.1006/jmcc.2000.1221. PMID11013132.